KLK3 and neoplasm: The number of treatment cycles was determined based on PSA kinetics, molecular tumor burden response via post-therapeutic single-photon emission computed tomography (SPECT/CT) imaging, and comprehensive evaluations of hematologic and chemistry parameters, as well as overall clinical status.